Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India

NACompletedINTERVENTIONAL
Enrollment

3,032

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Misoprostol

Selective administration of 800 mcg sublingual misoprostol to women with at least 350 mL blood loss within 1 hour following delivery

DRUG

Misoprostol

Universal administration of 600 mcg oral misoprostol given to all women within 5 minutes of delivery of the baby

Trial Locations (1)

586103

Deliveries at health sub-centers and homes, Vijayapura

All Listed Sponsors
collaborator

Sri B. M. Patil Medical College, Bijapur, Karnataka, India

UNKNOWN

collaborator

Jawaharlal Nehru Medical College

OTHER

collaborator

University of Illinois at Chicago

OTHER

collaborator

University of California, San Francisco

OTHER

lead

Gynuity Health Projects

OTHER

NCT01462422 - Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India | Biotech Hunter | Biotech Hunter